| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.0009 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |